Default company panoramic image
75027532 0543 4729 b2de fa06f831b4ae


GeneBalance markets bio-reagents and conducts R&D on treatment and diagnosis of neurodegenerations and tumors by targeting RNA splicing.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Brookline, MA, USA
  • Currency USD
  • Founded September 2009
  • Employees 3
  • Website

Company Summary

GeneBalance Inc., founded in 2009, is a bioscience company that focuses on commercialization of reagents, bioscience supplies and more than 1000 antibodies, production of which are outsourced. GeneBalance also conducts R/D on diagnosis and treatment of neurodegenerative diseases and cancers by targeting abnormal RNA splicing and by monitoring signature chimeric RNA biomarkers. We estimate that annual revenue will reach $100000-200000 in 2012.


  • Default avatar
    Jianhua zhou
    CEO and CSO

    2009-2011 CEO, GeneBalance
    2011-Curr Consultant, St Laurent Institute
    2010. MBA, Boston University
    2001-2010 Assistant Professor, UMass
    1998-2001 Assistant Professor, Tufts
    1995-1998. Postdoc. Harvard
    1989-1995. Ph.D. student, Pittsburgh
    1983-1987. B.S. Fudan University

  • Default avatar
    Susan Daudelin
    VP, Sales and Market

    2009-Curr VP, GeneBalance
    2008-Curr Director, Venture Development Center, UMass Boston
    2007-2010, MBA, UMass Boston
    2001-2007, Genzyme